09:47 AM EST - CryoCath Technologies Inc. : Medtronic Inc. agreed to buy Canada's CryoCath Technologies Inc. for about $400 million to strengthen the U.S-based medical device maker's presence in treating abnormal heart rhythms, or cardiac arrhythmias. CryoCath Technologies Inc.
shares T.CYT are trading up $4.06 at $8.50.
